Trial updateGlaucoma
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Recruiting. Phase 3. Registered enrolment: 130. AbbVie
Why it matters
Track this study through NCT06822738. No results are posted in this registry record.
The study at a glance
- Registry status
- Recruiting
- Phase
- Phase 3
- Registered enrolment
- 130
- Results posted
- No
- Sponsor
- AbbVie
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.